WELLS FARGO & COMPANY/MN - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,222,230
-9.3%
59,650
-12.1%
0.00%
Q2 2023$1,347,722
+22.2%
67,827
+5.4%
0.00%
Q1 2023$1,102,726
+2031.2%
64,374
+2334.7%
0.00%
Q4 2022$51,743
+99.0%
2,644
+63.9%
0.00%
Q3 2022$26,000
-77.8%
1,613
-81.0%
0.00%
Q2 2022$117,000
-37.1%
8,486
-28.2%
0.00%
Q1 2022$186,000
-64.6%
11,814
-51.0%
0.00%
Q4 2021$526,000
-14.6%
24,092
+16.9%
0.00%
Q3 2021$616,000
-47.3%
20,602
-21.9%
0.00%
Q2 2021$1,169,000
+2.1%
26,388
+2.2%
0.00%
Q1 2021$1,145,000
-37.4%
25,828
-22.6%
0.00%
Q4 2020$1,829,000
+285.9%
33,352
+61.0%
0.00%
Q3 2020$474,000
-31.3%
20,715
-37.1%
0.00%
Q2 2020$690,000
+91.7%
32,932
+27.6%
0.00%
Q1 2020$360,000
+1.7%
25,799
+66.0%
0.00%
Q4 2019$354,000
+95.6%
15,541
+0.1%
0.00%
Q3 2019$181,000
-15.8%
15,524
+8.3%
0.00%
Q2 2019$215,000
-64.5%
14,328
-58.4%
0.00%
Q1 2019$605,000
+18.2%
34,473
-0.2%
0.00%
Q4 2018$512,000
-33.8%
34,558
+10.0%
0.00%
Q3 2018$773,000
-73.0%
31,416
-78.5%
0.00%
-100.0%
Q2 2018$2,864,000145,9030.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders